Powder and solvent for solution for injection
Trade Name
NIMENRIX
-
Request Type
Powder and solvent for solution for injection
Drug Type
Biological Drug
Approval Date
SFDA Approved Use
Nimenrix is indicated for active immunisation of individuals from the age of 6 weeks against invasive meningococcal disease caused by Neisseria meningitidis groups A, C, W-135, and Y.